Facebook
Twitter
Telegram
Report an ErrorTransMedics Group Balance Sheet 2011-2024 | TMDX
Annual Balance Sheet TransMedics Group
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
54.4 M | -192 M | 9.62 M | 10.1 M | 14.1 M | 13.4 M | -3.28 M | - | - | - | - | - | - |
Long Term Debt |
447 M | 7.42 M | 35.2 M | 34.7 M | 34.1 M | 33.7 M | 6.85 M | - | - | - | - | - | - |
Long Term Debt Current |
2.04 M | 1.44 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 34.5 M | 34.4 M | 195 M | - | - | - | - | - | - |
Total Current Liabilities |
54.9 M | 23.7 M | 23.2 M | 11.9 M | 16.1 M | - | - | - | - | - | - | - | - |
Total Liabilities |
569 M | 89.8 M | 67 M | 48.1 M | 50.6 M | 47 M | 206 M | - | - | - | - | - | - |
Deferred Revenue |
1.96 M | 241 K | 250 K | 263 K | 166 K | 306 K | 239 K | - | - | - | - | - | - |
Retained Earnings |
-504 M | -479 M | -442 M | -398 M | -369 M | -336 M | -312 M | - | - | - | - | - | - |
Total Assets |
706 M | 277 M | 135 M | 152 M | 105 M | 42.2 M | 37 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
395 M | 201 M | 25.6 M | 24.6 M | 20.1 M | 20.7 M | - | - | - | - | - | - | - |
Book Value |
137 M | 187 M | 67.9 M | 104 M | 54.6 M | -4.82 M | -169 M | - | - | - | - | - | - |
Total Shareholders Equity |
137 M | 187 M | 67.9 M | 104 M | 54.6 M | -192 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet TransMedics Group
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
448 M | 447 M | 446 M | 446 M | 58.8 M | 7.42 M | 58.5 M | - | 35.3 M | 35.2 M | 35.1 M | 34.9 M | 34.8 M | 34.7 M | 34.7 M | 34.7 M | 34.7 M | 34.1 M | 34.1 M | 34.1 M | 34.1 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
564 M | 569 M | 563 M | 545 M | 94.5 M | 89.8 M | 87 M | - | 64.1 M | 67 M | 52.6 M | 51.5 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 50.6 M | 50.6 M | 50.6 M | 50.6 M | 47.9 M | 47.9 M | 47.9 M | 47.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.06 M | 1.96 M | 2.63 M | 244 K | 244 K | 241 K | 226 K | - | 247 K | 250 K | 320 K | 473 K | 432 K | 263 K | 263 K | 263 K | 263 K | 166 K | 166 K | 166 K | 166 K | 306 K | 306 K | 306 K | 306 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-492 M | -504 M | -508 M | -482 M | -481 M | -479 M | -472 M | - | -453 M | -442 M | -430 M | -417 M | -406 M | -398 M | -398 M | -398 M | -398 M | -369 M | -369 M | -369 M | -369 M | -336 M | -336 M | -336 M | -336 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
724 M | 706 M | 689 M | 690 M | 287 M | 277 M | 275 M | - | 124 M | 135 M | 131 M | 141 M | 146 M | 152 M | 152 M | 152 M | 152 M | 105 M | 105 M | 105 M | 105 M | 42.2 M | 42.2 M | 42.2 M | 42.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
350 M | 395 M | 427 M | 582 M | 195 M | 201 M | 204 M | 30.4 M | 17.9 M | 25.6 M | 22.5 M | 25.3 M | 26.7 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
159 M | 137 M | 126 M | 145 M | 193 M | 187 M | 188 M | - | 59.9 M | 67.9 M | 78.5 M | 89 M | 97.7 M | 104 M | 104 M | 104 M | 104 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | -5.72 M | -5.72 M | -5.72 M | -5.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
159 M | 137 M | 126 M | 145 M | 193 M | 187 M | 188 M | 50.9 M | 59.9 M | 67.9 M | 78.5 M | 89 M | 97.7 M | 104 M | 104 M | 104 M | 104 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | -192 M | -192 M | -192 M | -192 M | -169 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency